The Latest Breaking News from Quest Diagnostics

Quest Diagnostics’ Quarterly Earnings Preview: What You Need to Know

Quest Diagnostics is set to report its Q3 earnings next month, with analysts expecting single-digit year-over-year EPS growth.

Barchart · Oct 5

People with Lyme Antibodies Were Over Four Times as Likely to Carry Antibodies to Other Tick-Borne Germs

Nearly 30% of people with Lyme antibodies also had antibodies to another tick-borne germ. What that means and why it can change treatment.

Medical Daily · Sep 24

Nearly 1 in 3 People with Lyme Antibodies Also Carried Antibodies to Another Tick-Borne Pathogen, Most Often Babesia

A study of 193,260 patients found that 29.5% of those with Lyme antibodies also had antibodies to another tick-borne germ. Here is what that does and does not mean.

Medical Daily · Sep 23

Quest Diagnostics Stock: Analyst Estimates & Ratings

Quest Diagnostics is keeping analysts reasonably upbeat as steady execution and momentum continue supporting Wall Street confidence.

Barchart · May 25

Whoop is moving beyond wearables to test your blood, integrating the results with its AI-powered app — and its latest evolution is smarter than ever

Specialized Panels is a blood test which allows Whoop's in-app AI to 'deliver even more personalized, relevant insights' about your body.

TechRadar · Apr 16

How Is Quest Diagnostics’ Stock Performance Compared to Other Healthcare Stocks?

Quest Diagnostics has outpaced its healthcare peers over the past year, and analysts are maintaining a moderately positive outlook on its future performance.

Barchart · Mar 19

Do Wall Street Analysts Like Quest Diagnostics Stock?

Quest Diagnostics has outperformed the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects.

Barchart · Feb 18

What You Need To Know Ahead of Quest Diagnostics' Earnings Release

Quest Diagnostics is expected to unveil its fourth-quarter results soon, and analysts expect a single-digit growth in earnings.

Barchart · Jan 5

Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector?

Quest Diagnostics has outperformed the broader healthcare sector over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.

Barchart · Dec 15, 2025

Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings

Quest Diagnostics (NASDAQ:DGX) posted better-than-expected earnings for the third quarter on Tuesday.

Benzinga · Oct 22, 2025